XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 17.36%15.7B | 22.87%4.15B | 26.01%3.72B | 18.35%3.76B | 5.14%4.07B | 7.19%13.38B | 7.83%3.38B | 9.53%2.95B | 6.50%3.18B | 5.48%3.87B |
Operating revenue | 17.46%15.73B | 22.82%4.15B | 26.07%3.72B | 18.71%3.78B | 5.21%4.08B | 7.14%13.39B | 7.34%3.38B | 9.57%2.95B | 6.50%3.18B | 5.38%3.88B |
Cost of revenue | 20.01%8.28B | 26.87%2.12B | 27.60%2.15B | 21.44%2.13B | 5.08%1.88B | 6.56%6.9B | 8.58%1.67B | 9.99%1.69B | 7.02%1.75B | 1.41%1.79B |
Gross profit | 14.54%7.42B | 18.96%2.03B | 23.90%1.57B | 14.55%1.63B | 5.19%2.19B | 7.86%6.47B | 7.10%1.7B | 8.93%1.27B | 5.88%1.42B | 9.25%2.08B |
Operating expense | 20.32%3.19B | 6.25%867M | 51.61%893M | 36.70%853M | -1.61%613M | 5.57%2.65B | 8.95%816M | 2.08%589M | -3.55%624M | 15.58%623M |
Selling and administrative expenses | 5.59%1.97B | -20.23%493M | 35.46%531M | 27.15%548M | 1.90%429M | 7.07%1.86B | 12.57%618M | 5.09%392M | -7.71%431M | 20.29%421M |
-General and administrative expense | 5.59%1.97B | -20.23%493M | 35.46%531M | 27.15%548M | 1.90%429M | 7.07%1.86B | 12.57%618M | 5.09%392M | -7.71%431M | 20.29%421M |
Depreciation amortization depletion | 167.97%686M | 246.27%232M | 256.45%221M | 170.31%173M | -4.76%60M | -3.03%256M | 8.06%67M | -12.68%62M | -1.54%64M | -4.55%63M |
-Depreciation and amortization | 167.97%686M | 246.27%232M | 256.45%221M | 170.31%173M | -4.76%60M | -3.03%256M | 8.06%67M | -12.68%62M | -1.54%64M | -4.55%63M |
Other operating expenses | 0.94%539M | 8.40%142M | 4.44%141M | 2.33%132M | -10.79%124M | 4.91%534M | -5.07%131M | 1.50%135M | 12.17%129M | 13.01%139M |
Operating profit | 10.52%4.22B | 30.63%1.16B | -0.15%678M | -2.75%777M | 8.10%1.57B | 9.51%3.82B | 5.46%888M | 15.67%679M | 14.63%799M | 6.74%1.46B |
Net non-operating interest income expense | -59.16%-721M | -80.36%-202M | -90.00%-209M | -55.20%-194M | -9.43%-116M | -16.75%-453M | -4.67%-112M | -14.58%-110M | -28.87%-125M | -20.45%-106M |
Non-operating interest income | 116.13%67M | -66.67%4M | -55.56%4M | 520.00%31M | 460.00%28M | 72.22%31M | 300.00%12M | 28.57%9M | 0.00%5M | 66.67%5M |
Non-operating interest expense | 62.81%788M | 66.13%206M | 78.99%213M | 73.08%225M | 29.73%144M | 19.21%484M | 12.73%124M | 15.53%119M | 27.45%130M | 21.98%111M |
Other net income (expense) | 79.50%-41M | 59.88%-67M | -122.22%-20M | 818.75%115M | -325.00%-34M | -470.37%-200M | -542.31%-167M | -147.37%-9M | -148.48%-16M | -128.57%-8M |
Gain on sale of security | ---- | ---- | -460.00%-28M | 66.67%-5M | 854.55%83M | -640.00%-74M | -38.71%-43M | -145.45%-5M | -287.50%-15M | -650.00%-11M |
Earnings from equity interest | ---- | ---- | 0.00%2M | 200.00%1M | -33.33%2M | -50.00%5M | -75.00%1M | 0.00%2M | -133.33%-1M | 200.00%3M |
Special income (charges) | -196.95%-389M | 44.80%-69M | 200.00%6M | --119M | ---119M | -342.59%-131M | -12,600.00%-125M | -200.00%-6M | --0 | --0 |
-Less:Restructuring and merger&acquisition | 188.15%389M | -46.51%69M | 1,050.00%69M | --132M | --119M | --135M | --129M | --6M | --0 | --0 |
-Less:Other special charges | ---- | ---- | --1M | --6M | ---- | ---- | ---- | ---- | ---- | ---- |
-Gain on sale of business | ---- | ---- | --76M | --257M | ---- | -92.59%4M | 300.00%4M | --0 | --0 | ---- |
Other non- operating income (expenses) | --348M | --2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Income before tax | 9.25%3.46B | 46.31%891M | -19.82%449M | 6.08%698M | 6.11%1.42B | 0.41%3.17B | -14.10%609M | 9.80%560M | 3.95%658M | 2.91%1.34B |
Income tax | 37.15%742M | 53.92%157M | 1.08%94M | 92.77%160M | 25.86%331M | 6.08%541M | 137.21%102M | 1.09%93M | -30.25%83M | 2.73%263M |
Net income | 3.50%2.72B | 44.77%734M | -23.98%355M | -6.43%538M | 1.30%1.09B | -0.68%2.63B | -23.87%507M | 11.72%467M | 11.87%575M | 2.96%1.08B |
Net income continuous Operations | 3.50%2.72B | 44.77%734M | -23.98%355M | -6.43%538M | 1.30%1.09B | -0.68%2.63B | -23.87%507M | 11.72%467M | 11.87%575M | 2.96%1.08B |
Minority interest income | 3.13%66M | 100.00%18M | 9.09%12M | -6.67%14M | -24.14%22M | 12.28%64M | 0.00%9M | 10.00%11M | 15.38%15M | 16.00%29M |
Net income attributable to the parent company | 3.51%2.65B | 43.78%716M | -24.78%343M | -6.43%524M | 2.00%1.07B | -0.97%2.56B | -24.20%498M | 11.76%456M | 11.78%560M | 2.64%1.05B |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 3.51%2.65B | 43.78%716M | -24.78%343M | -6.43%524M | 2.00%1.07B | -0.97%2.56B | -24.20%498M | 11.76%456M | 11.78%560M | 2.64%1.05B |
Basic earnings per share | -0.40%12.55 | 32.93%3.31 | -29.78%1.58 | -9.85%2.47 | 5.70%5.38 | 3.03%12.6 | -21.45%2.49 | 16.58%2.25 | 16.60%2.74 | 7.16%5.09 |
Diluted earnings per share | -0.16%12.49 | 32.79%3.28 | -29.60%1.57 | -9.23%2.46 | 5.52%5.35 | 3.05%12.51 | -21.34%2.47 | 16.15%2.23 | 16.31%2.71 | 7.19%5.07 |
Dividend per share | 9.77%2.64 | 9.76%0.675 | 9.76%0.675 | 9.76%0.675 | 9.82%0.615 | 9.82%2.405 | 9.82%0.615 | 9.82%0.615 | 9.82%0.615 | 9.80%0.56 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |